@BillStewart415 @SherrisView @farid__jalali @MLS_Dave No! Per trials they (mRNA) were 95% effective against symptomatic disease (i.e. covid). That is the basis on which they were authorized.
It wasn't possible to measure efficacy against hospitalization and death because the trials were too small for that.
@BillStewart415@SherrisView@farid__jalali@MLS_Dave No！根据试验，它们（mRNA）对症状性疾病（即新冠病毒）的有效率为95%。这是他们获得授权的基础。
由于试验规模太小，无法衡量住院治疗和死亡的疗效。